These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36054369)

  • 1. Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Rajati Haghi M; Ghadam Soltani T; Rezaei A; Faghfouri A; Poustchian Gholkhatmi Z; Bakhshaee M
    Laryngoscope; 2022 Nov; 132(11):2209-2216. PubMed ID: 36054369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.
    Kasiri H; Rouhani N; Salehifar E; Ghazaeian M; Fallah S
    Int Immunopharmacol; 2021 Sep; 98():107871. PubMed ID: 34147912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial.
    Abdelalim AA; Mohamady AA; Elsayed RA; Elawady MA; Ghallab AF
    Am J Otolaryngol; 2021; 42(2):102884. PubMed ID: 33429174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial.
    Figueiredo LP; Paim PVDSL; Cerqueira-Silva T; Barreto CC; Lessa MM
    Braz J Otorhinolaryngol; 2024; 90(1):101356. PubMed ID: 37944311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial.
    Tragoonrungsea J; Tangbumrungtham N; Nitivanichsakul T; Roongpuvapaht B; Tanjararak K
    Clin Otolaryngol; 2023 Mar; 48(2):182-190. PubMed ID: 36336851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of any form of steroids in comparison with that of other medications on the duration of olfactory dysfunction in patients with COVID-19: A systematic review of randomized trials and quasi-experimental studies.
    Winn PZ; Hlaing T; Tun KM; Lei SL
    PLoS One; 2023; 18(8):e0288285. PubMed ID: 37531338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013876. PubMed ID: 36062970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In reference to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Vaira LA; De Riu G; Boscolo-Rizzo P; Hopkins C; Lechien JR
    Laryngoscope; 2023 Apr; 133(4):E29-E30. PubMed ID: 36495301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In response to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Bakhshaee M
    Laryngoscope; 2023 Apr; 133(4):E31. PubMed ID: 36495295
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.
    Abdelazim MH; Abdelazim AH
    Am J Rhinol Allergy; 2022 Nov; 36(6):841-848. PubMed ID: 35942688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different types of intranasal steroids for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COCOS trial:
    Schepens EJA; Boek WM; Boesveldt S; Stegeman I; Stokroos RJ; Kamalski DMA
    BMJ Open; 2022 Aug; 12(8):e060416. PubMed ID: 35948382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment.
    Shu CH; Lee PL; Shiao AS; Chen KT; Lan MY
    Laryngoscope; 2012 Apr; 122(4):747-50. PubMed ID: 22302665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.
    Schmidt F; Azar C; Goektas O
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
    Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
    Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.